News | March 30, 2009

GE, Archimedes to Collaborate on Coronary Heart Disease Screening Study

March 30, 2009 - GE Healthcare and Archimedes Inc., an independent Healthcare Modeling organization, announced at ACC that they will collaborate to launch a new virtual study to identify an enhanced diagnostic protocol for predicting coronary heart disease (CHD).

The virtual study applies a sophisticated computer model which simulates diagnostic methods for screening and predicting heart disease to help researchers better understand earlier treatments for the number one killer among men and women in the U.S.

Claudio Marelli, M.D., F.A.C.C., strategic medical leader for GE Healthcare said, “The Framingham score fails to predict 25 percent of coronary artery disease. Unconditional treatment might expose patients to unbeneficial treatments. Our collaboration with Archimedes will shed light on the cost-benefit of screening strategies for CHD - and on the value of imaging - to increase current risk stratification capacities to adjust the intensity of treatment accordingly.”

Despite recent progress in the screening and prevention of CHD, many people continue to be improperly identified through current risk measurement tools such as the Framingham Risk Score. The collaboration will allow for the evaluation of screening strategies to determine the potential of an improved model for calculating the risk of CHD based on new technologies and risk factors.

“Leading innovators like GE Healthcare are embracing healthcare modeling,” said Barbara Peskin, principal investigator for Archimedes. “We are delighted to partner with GE Healthcare in its commitment to investigating preventive health through the use of the Archimedes Model.”

For more information: www.gehealthcare.com and www.archimedes.com

Related Content

Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT
Technology | Computed Tomography (CT) | June 18, 2019
Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Feature | Computed Tomography (CT) | May 30, 2019 | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging mod
Vast Majority of Heavy Smokers Not Screened for Lung Cancer
News | Lung Cancer | May 29, 2019
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...